112 results
Page 3 of 6
8-K
8zul87 9j2p5f
26 Oct 21
Departure of Directors or Certain Officers
4:19pm
8-K
EX-99.3
ocho8ce1d9jf6366l
4 Jun 21
Harpoon Therapeutics Presents Updated Interim Clinical Data for the PSMA-targeting TriTACĀ® HPN424 at the 2021 ASCO Annual Meeting
4:40pm
8-K
EX-99.2
srbo8t
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
8-K
EX-1.1
pjrjzt67
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
424B5
volrw87r3pm12vk01xm
7 Jan 21
Prospectus supplement for primary offering
4:16pm
424B5
6ch r7byny15r
6 Jan 21
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
gk2g2307x esxjzfwhu
11 Dec 20
Other Events
5:06pm
8-K
EX-99.2
5x2iffvamc gc
29 May 20
Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose
4:03pm
DEF 14A
40hnke7cu82e
17 Apr 20
Definitive proxy
5:02pm
S-3
ostyxzj4lmagyynyn
13 Mar 20
Shelf registration
4:53pm